15th Pharma and Clinical Trials in Canada Summit

$499.00

SKU: PHP15033 Category:

Description

Report Code: PHP15033 | September 23-24, 2015 | Toronto, ON

Article 1. Introductory Comments

Jack Corman
Founder and President
Canadian Association for Independent Clinical Research

Article 2. Initiatives for Enhancing the Canadian Clinical Research Environment

Dr. Shurjeel Choudhri
Senior Vice President and Head, Medical and Scientific Affairs
Bayer Inc.

Article 3. Strengthening the Competitiveness of the Clinical Research Sector in Canada

Laura Accettola
Director, Global Study Operations, Amgen Canada
CCTCC National Advisory Group

Article 4. ROUNDTABLE 1 – Challenges and Opportunities for Site Selection & Initiation

Elise Beausoleil
Director Late Phase Research
Lundbeck Canada Inc.

Article 5. ROUNDTABLE 1 – Site Selection and Study Start-Up

Doreen D’Souza
Country Head Global Site Management, Canada
Bayer Inc.

Article 6. ROUNDTABLE 1 – Challenges and Opportunities for Site Selection & Initiation

Robert Huizinga
Vice President, Clinical Affairs
Aurinia Pharmaceuticals Inc.

Article 7. Roundtable 3 – Site Perspectives – Challenges and Opportunities for Site Initiation

Joanne Gavalakis
Head, Clinical Research
Montreal Heart Innovations Coordinating Centre
A division of the Montreal Heart Institute

Pierre Gervais
President
Q&T Research

Karri Venn
Director of Research
LMC Diabetes & Endocrinology

Article 8. Coming to a Middle Ground – Balancing Sponsor and Site Expectations

Dex Bilkic
Leader, Business Support Group
Boehringer Ingelheim Canada

Article 9. Challenges and Opportunities in Contract Negotiations

Pierre Gervais
President
Q&T Research

Katie Porter
Director of Research Administration
Hamilton Health Sciences Corporation

Article 10. Wayne Gretzky on Clinical Research – Where in the World is the Puck Going to Be? And How Will Canada Get There?

Greg Koski, PhD, MD
President and Chief Executive Officer
Alliance for Clinical Research Excellence and Safety (ACRES)

Article 11. Challenges in Recruitment and Retention: Rare Disease Clinical Research as a Driver of Change

Brenda Cooperstone, MD
Vice President,Medicines Development Group
Pfizer, Inc.

Article 12. Ethical Reviews in Canada – Challenges, Recommendations and Practical Solutions

Jack Corman
Founder and President
Canadian Association for Independent Clinical Research

Article 13. Clinical Trials Ontario – Making Ontario a Preferred Location for Global Clinical Trials while Maintaining the Highest Ethical Standards

Susan Marlin
President and CEO
Clinical Trials Ontario

Article 14. Patient Protection, Engagement & Informed Consent: Virtual Consent Platform

Ronald Heslegrave, PhD
Corporate Chief of Research
William Osler Health System

Article 15. TransCelerate Overview

Tozheg Roshankar
Regional Research Manager
Eli Lilly Canada Inc.

Lesley Barnett
Director Clinical Development – Canada
GlaxoSmithKline Inc.

Article 16. Canadian Clinical Trials Asset Map (CCTAM)

Elena Aminkova
Project Manager
Canadian Clinical Trials Asset Map (CCTAM)

Article 17. Keeping Investigators Interested in Clinical Trials

Sharon Cohen, MD FRCPC
Director
Toronto Memory Program